Japanese Journal of Clinical Immunology
Online ISSN : 1349-7413
Print ISSN : 0911-4300
ISSN-L : 0911-4300
IgD-λ type multiple myeloma associated with IgG-κ type benign monoclonal gammopathy
Hajime ShimadaSusumu NishinaritaYoshihusa KishigamiTakashi HayamaUmihiko SawadaTakashi HorieNoriko NakamuraMariko KatoMakoto HiranoOsamu NakamuraYuji Sudo
Author information
JOURNAL FREE ACCESS

1995 Volume 18 Issue 2 Pages 235-240

Details
Abstract
A 76-year-old man was admitted to Kisen hospital because of lumbago and chest pain. Laboratory examinations revealed a chronic renal failure with marked elevation of the serum BUN (48.8mg/dl) and creatinine levels (8.2mg/dl). The serum electrophoresis demonstrated a hypergammaglobulinemia with M peaks. An immunoelectrophoresis demonstrated monoclonal IgD-λ and IgG-κ proteins in the serum, and λ-type Bence Jones protein in the urine (0.4g/day). Bone marrow smears revealed an abnormal proliferation of atypical plasma cells (43%). A systemic X-ray examination of the skeletal system showed systemic osteoporosis without punched out lesion. The patient was diagnosed as having IgD-λ type multiple myeloma and IgG-κ type benign monoclonal gammopathy by quantifing concentration of two M proteins (1, 160mg/dl in IgD, 1, 179mg/dl in IgG, respectively). A combination chemotherapy with melphalan and prednisolone was administered monthly for multiple myeloma, and hemodyalysis for the renal failure was performed 3 times a week. A marked improvement of his laboratory findings including a diminution of the serum IgD-λ M-protein was obtained. Ort the other hand, IgG-κ M-protein level was unchanged. Two M-protein levels showed a different behavior after the combination chemotherapy. Although the patient died of congestive heart failure, the partial remission of multiple myeloma has been maintained for 16 months with chemotherapy.
Content from these authors
© The Japan Society for Clinical Immunology
Previous article Next article
feedback
Top